1613265-38-5
Chemical Structure
Zalsenertant tetraxetan
Synonym(s): IPN-01087
- CAS No.: 1613265-38-5
- Formula:C58H84N10O13
- Molecular Weight:1129.35
InChIKey: NQKDJWKHSVVCRZ-UHFFFAOYSA-N
SMILES: CN(CCCN(C)CCCN(C)C(CN(CCN(CC1)CC(O)=O)CCN(CCN1CC(O)=O)CC(O)=O)=O)C(C2=CC(C(C)C)=C(N3C(C4=C(OC)C=CC=C4OC)=CC(C(NC5(C(O)=O)[C@H]6C[C@@H]7C[C@@H](C[C@H]5C7)C6)=O)=N3)C=C2)=O
Biological Activity: Zalsenertant tetraxetan (IPN-01087) is a DOTA-conjugated antagonist of the neurohypophyseal hormone receptor subtype 1 (NTSR1). Zalsenertant tetraxetan is labeled with the radioactive isotope Lu-177 (177Lu), which can be used for molecular imaging to identify potential responders. Zalsenertant tetraxetan can be used in the radiotherapy research of solid tumors[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zalsenertant tetraxetan | Zalsenertant tetraxetan (IPN-01087) is a DOTA-conjugated antagonist of the neurohypophyseal hormone receptor subtype 1 (NTSR1). Zalsenertant tetraxetan is labeled with the radioactive isotope Lu-177 (177Lu), which can be used for molecular imaging to identify potential responders. Zalsenertant tetraxetan can be used in the radiotherapy research of solid tumors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
